Search results for " Probiotics"

showing 6 items of 26 documents

From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?

2011

The gut of a healthy adult harbours a myriad of different microbial species. It is estimated that approximately 10 14 are present in total bacterial colony forming units (CFU). Each colony colonizes a specific intestinal tract. In healthy adult, the main control of intestinal bacterial colonization occurs through gastric acidity but also other factors can influence the intestinal microenvironment such as pH, temperature, competition among different bacterial strains, peristalsis, drugs, radiotherapy and much more. Impaired microbial homeostasis leads to an alteration of the permeability of tissue, together with the activation of the intestinal immune system MALT (mucosal associated lymphoid…

Settore MED/07 - Microbiologia E Microbiologia ClinicaProbioticsMycobacterium Infections NontuberculousNontuberculous MycobacteriaInflammatory Bowel DiseasesSettore MED/18 - Chirurgia GeneraleTreatment OutcomeCrohn DiseaseRisk FactorsChronic DiseaseHumansColitis Ulcerativeintestinal microflora imbalance intestinal immune system chronic intestinal diseases mycobacteria probioticsIntestinal MucosaAnnali italiani di chirurgia
researchProduct

PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD)

2014

Summary: This work reports a clinical trial performed at palermo University Hospital "paolo Giaccone". From January 2004 to December 2011, 79 patients were enrolled (40 men and 39 women). All patients suffered from Inflammatory Bowel Disease (IBD) and were subjected to orthopedic consultation at the institute of Orthopaedics, University Hospital of palermo, for arthropathy to IBD. The patients were divided into two groups (A and B) and dealt with different therapies for the resolution of the inflammatory picture of the colonic mucosa and the treatment of the extraintestinal articular manifestations. Group A was treated with drug therapy: Diclofenac (75 mg im/ day for 10 days9 and Mesalazine…

Settore MED/18 - Chirurgia GeneraleSettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaSettore BIO/16 - Anatomia UmanaIntestinal Bowel Disease probiotics extraintestinal manifestationf ob IBD
researchProduct

Probiotics in the prevention and treatment of atopic dermatitis

2020

The use of probiotic supplements might change the composition of the intestinal flora of children, subsequently modulating the immune system's reactivity. The effects of probiotic administration for the prevention/treatment of allergic diseases and atopic dermatitis, in particular, are still so controversial that no definitive recommendation can be made at this stage. Differences in strain specificity, timing, and length of administration all contribute to diversifying the conclusions of this review.

atopic dermatitiallergic diseasesImmunologyEczemaDermatitis Atopiclaw.invention03 medical and health sciencesProbioticSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineImmune systemlawFlora (microbiology)HypersensitivitymedicineHumansImmunology and Allergy030212 general & internal medicineChildatopic dermatitisbusiness.industryProbioticsAtopic dermatitismedicine.diseaseinfantStrain specificityallergic disease030228 respiratory systemDietary SupplementsPediatrics Perinatology and Child HealthImmunologyallergic diseases; atopic dermatitis; child; eczema; infant; probioticsbusinessPediatric Allergy and Immunology
researchProduct

Probiotic properties of Brevibacillus brevis and its influence on sea bass (Dicentrarchus labrax) larval rearing

2012

Efficacy of Brevibacillus brevis strain and its influence on larval rearing of sea bass (Dicentrarchus labrax) were investigated in the present work. Biochemical analyses permit to identify this strain as B. brevis. This bacterium has an inhibitory effect against fish pathogenic bacteria, especially the genus of Vibrio. Enzymatic characterization revealed that B. brevis was lipase positive, amylase, lecithinase and caseinase negative. Adherence assays to abiotic surfaces and challenge test with Artemia larvae demonstrate that B. brevis was fairly adherent and play an important role in the enhancement of the protection of Artemia culture against pathogens. Treatment of sea bass larvae with B…

biologyfungiZoologyPathogenic bacteriaPlant Sciencemedicine.disease_causebiology.organism_classificationMicrobiologylaw.inventionProbioticCaseinaseInfectious DiseasesBrevibacillus brevis probiotics antagonism adhesion Artemia Sea bass larvae aquacultureBrevibacillus brevislawSettore BIO/10 - Biochimicamedicinebiology.proteinDicentrarchusAmylaseSettore BIO/06 - Anatomia Comparata E CitologiaSea bassLecithinaseAfrican Journal of Microbiology Research
researchProduct

The intestinal ecosystem and probiotics

2016

The term "probiotic" comes from the greek "pro bios" and means "pro life": Nowadays, an increasing number of pharmaceutical preparations and functional foods are enriched with probiotics and for the patients it is increasingly important to receive information needed to know how to orient in the choice. The benefits from probiotics are many and include the modulation of the intestinal microflora (stimulation of beneficial bacteria and inhibition of pathogens), the support of bowel function and the stimulation of the immune system. This broad spectrum of beneficial effects to maintain efficient the intestinal ecosystem. Therefore, probiotics are an useful tool to prevent the formation of diso…

dysbiosis intestinal microflora Inflammatory Bowel Disease IBD probiotics
researchProduct

Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial.

2011

Background: Lactoferrin is a mammalian milk glycoprotein involved in innate immunity. Recent data show that bovine lactoferrin (bLF) prevents late-onset sepsis in preterm very low birth weight (VLBW) neonates. Methods: This is a secondary analysis of data from a multicenter randomized controlled trial where preterm VLBW neonates randomly received bLF (100 mg/day; group A1), bLF + Lactobacillus rhamnosus GG (106 colony-forming units per day; group A2), or placebo (group B) for 6 weeks. Here we analyze the incidence rates of fungal colonization, invasive fungal infection (IFI), and rate of progression from colonization to infection in all groups. Results: This study included 472 neonates who…

fungal sepsisDiseasesInfant Premature DiseasesPediatricsGastroenterologylactoferrin; VLBW neonates; Candida; fungal sepsis; prophylaxisGroup BSettore MED/38 - Pediatria Generale E SpecialisticaAnti-Infective AgentsInfant Very Low Birth WeightCandidabiologyLactoferrinBovine lactoferrin fungal infections very low birth weight newbornsPerinatology and Child Healthlactoferrinprophylaxismedicine.symptomInfant Prematuremedicine.medical_specialtyFungal sepsisPlaceboSepsisLactobacillus rhamnosusIntolerancesInternal medicinemedicineAnimalsHumansfungal sepsiAdverse effectPrematureProphylaxisbusiness.industryVery Low Birth WeightProbioticsInfant NewbornInfantNewbornbiology.organism_classificationmedicine.diseaseLactoferrinLow birth weightMycosesVLBW neonatesPediatrics Perinatology and Child HealthImmunologyCandida; Fungal sepsis; Lactoferrin; Prophylaxis; VLBW neonates; Animals; Anti-Infective Agents; Cattle; Humans; Infant Newborn; Infant Premature; Infant Premature Diseases; Lactoferrin; Mycoses; Probiotics; Infant Very Low Birth Weight; Pediatrics Perinatology and Child Healthbiology.proteinCattlebusiness
researchProduct